Genetic ablation of PKM2 in myeloid cells exerts a protecting effect against LPS induced endotoxemia in mice, while the pharmaceutical inhibition of PKM2 using shikonin improved mice survival rate [23]. This evidence concerns the gene PKM and serum lipopolysaccharide activity.